Form 4 for GH Guardant Health, Inc.
Accepted 2023-03-16 00:00:00 ET · period of report 2023-03-14 · accession 0001576280-23-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-03-16 | 2023-03-14+ | GH | Eltoukhy Helmy | Co-CEO, Dir | P - Purchase | $26.31 | +93.1K | 2.05M | +5% | +$2.45M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2023-03-14 | P | A | 84,452 | $26.33 | 2,040,638 | D | — | — | (F1) Represents the weighted average price of shares purchased at prices that ranged from $26.245 to $26.50. |
| 2 | Common | COMMON STOCK | 2023-03-15 | P | A | 8,600 | $26.15 | 2,049,238 | D | — | — | (F2) Represents the weighted average price of shares purchased at prices that ranged from $26.13 to $26.27. |